Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 186

1.

IFI16 Expression Is Related to Selected Transcription Factors during B-Cell Differentiation.

Piccaluga PP, Agostinelli C, Fuligni F, Righi S, Tripodo C, Re MC, Clò A, Miserocchi A, Morini S, Gariglio M, Ferri GG, Rinaldi-Ceroni A, Piccin O, De Andrea M, Pileri SA, Landolfo S, Gibellini D.

J Immunol Res. 2015;2015:747645. doi: 10.1155/2015/747645. Epub 2015 Jun 22.

2.

Calcaneal quantitative ultrasound (QUS) and dual X-ray absorptiometry (DXA) bone analysis in adult HIV-positive patients.

Clò A, Gibellini D, Damiano D, Vescini F, Ponti C, Morini S, Miserocchi A, Musumeci G, Calza L, Colangeli V, Viale P, Re MC, Borderi M.

New Microbiol. 2015 Aug;38(3):345-356. Epub 2015 Jul 6.

3.

Durable viral suppression in an HIV-infected patient in the absence of antiretroviral therapy.

Bon I, Musumeci G, Pavoni M, Miserocchi A, Lo Presti A, Morini S, Della Vittoria A, Gibellini D, Re MC, Caio G.

New Microbiol. 2015 Apr;38(2):289-92. Epub 2015 Apr 29.

4.

High-throughput genotyping of high-risk Human Papillomavirus by MALDI-TOF Mass Spectrometry-based method.

Cricca M, Marasco E, Alessandrini F, Fazio C, Prossomariti A, Savini C, Venturoli S, Chieco P, De Carolis S, Bonafè M, Re MC, Garagnani P, Mantovani V.

New Microbiol. 2015 Apr;38(2):211-23. Epub 2015 Apr 29.

5.

V3 net charge: additional tool in HIV-1 tropism prediction.

Montagna C, De Crignis E, Bon I, Re MC, Mezzaroma I, Turriziani O, Graziosi C, Antonelli G.

AIDS Res Hum Retroviruses. 2014 Dec;30(12):1203-12. doi: 10.1089/aid.2014.0006.

PMID:
25322170
6.

HIV-1 coreceptor usage in paired plasma RNA and proviral DNA from patients with acute and chronic infection never treated with antiretroviral therapy.

Bon I, Turriziani O, Musumeci G, Clò A, Montagna C, Morini S, Calza L, Gibellini D, Antonelli G, Re MC.

J Med Virol. 2015 Feb;87(2):315-22. doi: 10.1002/jmv.24036. Epub 2014 Aug 20.

PMID:
25138591
7.

Prevalence of sub-clinical vertebral fractures in HIV-infected patients.

Borderi M, Calza L, Colangeli V, Vanino E, Viale P, Gibellini D, Re MC.

New Microbiol. 2014 Jan;37(1):25-32. Epub 2014 Jan 15.

8.

Effects of human immunodeficiency virus on the erythrocyte and megakaryocyte lineages.

Gibellini D, Clò A, Morini S, Miserocchi A, Ponti C, Re MC.

World J Virol. 2013 May 12;2(2):91-101. doi: 10.5501/wjv.v2.i2.91. Review.

9.

Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group.

Svicher V, Alteri C, Montano M, Nori A, D'Arrigo R, Andreoni M, Angarano G, Antinori A, Antonelli G, Allice T, Bagnarelli P, Baldanti F, Bertoli A, Borderi M, Boeri E, Bon I, Bruzzone B, Barresi R, Calderisi S, Callegaro AP, Capobianchi MR, Gargiulo F, Castelli F, Cauda R, Ceccherini-Silberstein F, Clementi M, Chirianni A, Colafigli M, D'Arminio Monforte A, De Luca A, Di Biagio A, Di Nicuolo G, Di Perri G, Di Santo F, Fadda G, Galli M, Gennari W, Ghisetti V, Costantini A, Gori A, Gulminetti R, Leoncini F, Maffongelli G, Maggiolo F, Maserati R, Mazzotta F, Meini G, Micheli V, Monno L, Mussini C, Nozza S, Paolucci S, Palù G, Parisi S, Parruti G, Pignataro AR, Quirino T, Re MC, Rizzardini G, Sanguinetti M, Santangelo R, Scaggiante R, Sterrantino G, Turriziani O, Vatteroni ML, Viscoli C, Vullo V, Zazzi M, Lazzarin A, Perno CF.

Infection. 2014 Feb;42(1):61-71. doi: 10.1007/s15010-013-0510-3. Epub 2013 Oct 22.

10.

Peptide-derivatized SB105-A10 dendrimer inhibits the infectivity of R5 and X4 HIV-1 strains in primary PBMCs and cervicovaginal histocultures.

Bon I, Lembo D, Rusnati M, Clò A, Morini S, Miserocchi A, Bugatti A, Grigolon S, Musumeci G, Landolfo S, Re MC, Gibellini D.

PLoS One. 2013 Oct 7;8(10):e76482. doi: 10.1371/journal.pone.0076482. eCollection 2013.

11.

HIV-related mechanisms in atherosclerosis and cardiovascular diseases.

Gibellini D, Borderi M, Clò A, Morini S, Miserocchi A, Bon I, Ponti C, Re MC.

J Cardiovasc Med (Hagerstown). 2013 Nov;14(11):780-90. doi: 10.2459/JCM.0b013e3283619331. Review.

PMID:
23656915
12.

Prevalence of R5 strains in multi-treated HIV subjects and impact of new regimens including maraviroc in a selected group of patients with CCR5-tropic HIV-1 infection.

Bon I, Clò A, Borderi M, Colangeli V, Calza L, Morini S, Miserocchi A, Cricca M, Gibellini D, Re MC.

Int J Infect Dis. 2013 Oct;17(10):e875-82. doi: 10.1016/j.ijid.2013.02.020. Epub 2013 Apr 15.

13.

Recent and long-lasting infections: the need for avidity testing in HIV-1 infected subjects.

Re MC, Bon I, Grandi N, Miserocchi A, Morini S, Clo A, Furlini G, Gibellini D.

New Microbiol. 2012 Oct;35(4):407-14. Epub 2012 Oct 1.

14.

Antiretroviral molecules and cardiovascular diseases.

Gibellini D, Borderi M, Clò A, Morini S, Miserocchi A, Bon I, Re MC.

New Microbiol. 2012 Oct;35(4):359-75. Epub 2012 Oct 1. Review.

15.

Guidelines for the qualitative detection of viral genomes in dried blood spots.

Gibellini D, De Crignis E, Re MC.

Methods Mol Biol. 2012;903:21-34. doi: 10.1007/978-1-61779-937-2_2.

PMID:
22782809
16.

Performance of genotypic tropism testing on proviral DNA in clinical practice: results from the DIVA study group.

Svicher V, Alteri C, Montano M, D'Arrigo R, Andreoni M, Angarano G, Antinori A, Antonelli G, Allice T, Bagnarelli P, Baldanti F, Bertoli A, Borderi M, Boeri E, Bon I, Bruzzone B, Callegaro AP, Capobianchi MR, Carosi G, Cauda R, Ceccherini-Silberstein F, Clementi M, Chirianni A, Colafigli M, D'Arminio Monforte A, De Luca A, Di Biagio A, Di Nicuolo G, Di Perri G, Di Pietro M, Di Santo F, Fabeni L, Fadda G, Galli M, Gennari W, Ghisetti V, Giacometti A, Gori C, Gori A, Gulminetti R, Leoncini F, Maffongelli G, Maggiolo F, Manca G, Gargiulo F, Martinelli C, Maserati R, Mazzotta F, Meini G, Micheli V, Monno L, Mussini C, Narciso P, Nozza S, Paolucci S, Pal G, Parisi S, Parruti G, Pignataro AR, Pollicita M, Quirino T, Re MC, Rizzardini G, Santangelo R, Scaggiante R, Sterrantino G, Turriziani O, Vatteroni ML, Vecchi L, Viscoli C, Vullo V, Zazzi M, Lazzarini A, Perno CF; DIVA group.

New Microbiol. 2012 Jan;35(1):17-25. Epub 2012 Jan 10.

17.

Prospective evaluation of bone markers, parathormone and 1,25-(OH)₂ vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz.

Focà E, Motta D, Borderi M, Gotti D, Albini L, Calabresi A, Izzo I, Bellagamba R, Narciso P, Sighinolfi L, Clò A, Gibellini D, Quiros-Roldan E, Brianese N, Cesana BM, Re MC, Torti C.

BMC Infect Dis. 2012 Feb 14;12:38. doi: 10.1186/1471-2334-12-38.

18.

Analysis of the effects of HIV-1 Tat on the survival and differentiation of vessel wall-derived mesenchymal stem cells.

Gibellini D, Miserocchi A, Tazzari PL, Ricci F, Clò A, Morini S, Ponti C, Pasquinelli G, Bon I, Pagliaro P, Borderi M, Re MC.

J Cell Biochem. 2012 Apr;113(4):1132-41. doi: 10.1002/jcb.23446.

PMID:
22095559
19.

Prevalence of hypovitaminosis D and factors associated with vitamin D deficiency and morbidity among HIV-infected patients enrolled in a large Italian cohort.

Vescini F, Cozzi-Lepri A, Borderi M, Re MC, Maggiolo F, De Luca A, Cassola G, Vullo V, Carosi G, Antinori A, Tozzi V, Monforte AD; Icona Foundation Study Group.

J Acquir Immune Defic Syndr. 2011 Oct 1;58(2):163-72. doi: 10.1097/QAI.0b013e31822e57e9.

PMID:
21826011
20.

HIV-1 and recombinant gp120 affect the survival and differentiation of human vessel wall-derived mesenchymal stem cells.

Gibellini D, Alviano F, Miserocchi A, Tazzari PL, Ricci F, Clò A, Morini S, Borderi M, Viale P, Pasquinelli G, Pagliaro P, Bagnara GP, Re MC.

Retrovirology. 2011 May 25;8:40. doi: 10.1186/1742-4690-8-40.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk